


Searching News Database: left ventricular hypertrophy
HSMN NewsFeed - 9 May 2016
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
HSMN NewsFeed - 27 Nov 2009
Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia
Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia
HSMN NewsFeed - 5 Nov 2009
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
HSMN NewsFeed - 7 Feb 2007
NxStage(R) Medical and DaVita Announce Agreement for Home Hemodialysis Using the NxStage System One(TM)
NxStage(R) Medical and DaVita Announce Agreement for Home Hemodialysis Using the NxStage System One(TM)
Additional items found! 13
Members Archive contains
13 additional stories matching:
left ventricular hypertrophy
(Password required)
left ventricular hypertrophy
(Password required)
